WhaleWatch
Sign inGet started
Smart Money Alert
Arisinfra Solutions Limited logo

Arisinfra Solutions Limited

Bulk Deal
ARISOther Construction MaterialsMarket Cap₹1K Cr
AS
Astorne Capital
Foreign Investor
The move
This is the latest moveSign in to see it
About Arisinfra Solutions Limited
Visit stock

A construction materials supplier serving real estate and infrastructure developers across India. Arisinfra Solutions provides essential building materials to support large-scale construction projects and contractor operations nationwide. The company focuses on delivering quality materials to meet the growing demand in India's infrastructure and real estate development sectors, working directly with developers and construction firms to support their project requirements.

About Astorne Capital
Visit investor

Astorne Capital is a Singapore-based variable capital company managed by fund manager Prosperitas Capital, investing in Indian listed and SME equities.

Get the next move the moment it happens.
Follow Astorne Capital and Arisinfra Solutions Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Arisinfra Solutions Limited shareholdersAstorne Capital's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Arisinfra Solutions Limited
More moves in Arisinfra Solutions Limited
Mr. Siddharth Bhaskar Shah
Direction, size, price and stake change for this move, with what it means for the company.
18 Sept 2026. Sign in to see this move
Mr. Siddharth Bhaskar ShahIncreased
Promoter Siddharth Bhaskar Shah bought 13.18 lakh shares of Arisinfra Solutions for ₹16.59 Cr at ₹125.83 apiece through a market purchase, increasing his stake from 0.95% to 2.56%.
17 Sept 2026
Read more
Mahevarsh FinconExited
Mahevarsh Fincon, which previously held 1.31 percent of Arisinfra Solutions Limited, has dropped off the company's latest disclosed shareholder list, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
20 Jul 2026
Read more
Motilal Oswal Mutual FundNew position
Motilal Oswal Mutual Fund entered Arisinfra Solutions with 41,41,203 shares, a 5.06% stake worth ₹45.7 Cr, crossing the 5% disclosure threshold.
20 Jul 2026
Read more
NeomileDecreased
Neomile decreased its stake in Arisinfra Solutions Limited from 5.72% to 1.01%, selling 38.5 lakh shares worth ₹42.45 Cr. This move reduced Neomile's holding in Arisinfra Solutions by 4.05%.
20 Jul 2026
Read more
See all moves
AS
More moves by Astorne Capital
Innovision LimitedExited
Astorne Capital, which last reported a 1.55 percent stake in Innovision Limited, is no longer listed among the company's named shareholders, indicating either a complete exit or a reduction to below the 1 percent disclosure threshold.
INNOVISION22 Jul 2026
Read more
Alpex SolarDecreased
Astorne Capital decreased its stake in Alpex Solar from 1.22% to 1.17% by selling 11,000 shares. The value of the shares sold is ₹94.22 lakh, calculated at a share price of ₹856.55.
ALPEXSOLAR21 Jul 2026
Read more
Sai Parenterals LimitedExited
Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
SAIPARENT21 Jul 2026
Read more
Arisinfra Solutions LimitedIncreased
Astorne Capital increased its stake in Arisinfra Solutions by purchasing 1,93,241 shares, raising its holding from 1.21% to 1.44%. The shares were valued at approximately ₹2.13 Cr, at a price of ₹110.39 per share.
ARIS20 Jul 2026
Read more
Senores Pharmaceuticals LimitedIncreased
Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares. The value of its increased holding is ₹12.93 Cr based on Senores Pharmaceuticals' share price of ₹1405.10.
SENORES20 Jul 2026
Read more
See all moves